Return to Exhibit Hall 

zoll.com/products/supersaturated-oxygen-therapy  

                                                                                                          

TherOx, a ZOLL Medical company, is based out of Irvine, CA, focused on the development of SuperSaturated Oxygen Therapy and improving treatment of acute myocardial infarctions. SSO2 Therapy provides interventional cardiologists with the first treatment option beyond percutaneous coronary intervention (PCI) to salvage heart muscle in heart attack patients.

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, supersaturated oxygen therapy, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.
 

Contact Information

Michael Giancola
mgiancola@zoll.com
Mobile: (617) 510-0564

 

Production Information

SSO2 Animation for Clinicians | SuperSaturated Oxygen Therapy for Acute Myocardial Infarct | TherOx

The SuperSaturated Oxygen (SSO2) Therapy System

SuperSaturated Oxygen (SSO2) Therapy for STEMI

SSO2 - How it Works

SSO2 Therapy Clinical Overview

Citations and Publications

PDF iconClinical Compendium.pdf

PDF iconThe Next Step in STEMI Treatment Post-PCI.pdf